Clinical Trials List
2014-07-01 - 2020-03-01
Phase II
Terminated5
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Liang-Chih Liu Division of General Surgery
- Chih-Jung Chen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 郭文宏 Division of General Surgery
- 陳怡君 Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- 林璟宏 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 黃文聰 Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 林明賢 Division of Hematology & Oncology
- 陳威宇 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Ta-Chung Chao 無
- 邱仁輝 無
- 金光亮 無
- Chun-Yu Liu 無
- 王國鐘 無
- 賴亦貞 無
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 沈士哲 無
- Hsien-Kun Chang 無
- Wen-Chi Shen 無
- Chi-Chang Yu 無
- 張潤忠 無
- Yung-Chang Lin 無
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
120 participants
